Product
TCR-MAGE-A4 T-Cells
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
A Single-arm, Open-label, Dose Exploratory Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Autologous Humanized MAGE-A4-directed T Cell Receptor Engineered T Cell (JWTCR001) in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-12-31